Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Print this page Email this page Users Online: 465

  Table of Contents  
CASE REPORT
Year : 2022  |  Volume : 15  |  Issue : 5  |  Page : 785-787  

A rare case of Herpes Zoster in a child involving dermatomes V1 and V2


Department of Pediatrics, Kalinga Institute of Medical Sciences, KIIT Deemed University, Bhubaneswar, Odisha, India

Date of Submission18-Apr-2021
Date of Decision05-Jul-2021
Date of Acceptance05-Jul-2021
Date of Web Publication28-Jan-2022

Correspondence Address:
Prof. Nirmal Kumar Mohakud
Department of Pediatrics, Kalinga Institute of Medical Sciences, KIIT Deemed University, Bhubaneswar, Odisha
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mjdrdypu.mjdrdypu_276_21

Rights and Permissions
  Abstract 


Herpes zoster (HZ) is rarely found in healthy children but may be attributed to immunocompromised children. Latent varicella-zoster virus (VZV) might have source from intrauterine exposure, chicken pox vaccination, or exposure to wild VZV. A 2 ½-year-old healthy boy presented with a painful red vesicular rashes with blisters on the right upper cheek, periorbital area, temporal and nasal area extending over the dermatomes V1 and V2 of 3 days' duration. There was an involvement of the right eye causing conjunctivitis. He had persistent frontal and temporal headache on the day 10 of the disease. Computed tomography scan of the brain reveals no abnormality. The child responded well to symptomatic management and routine skin care. Medications such as cetrizine, sup acyclovir, and local acyclovir ointment and emollients were given. Acyclovir was used orally in a dose of 20 mg/kg body weight every 6 hourly for 7 days. The patient recovered well in 10 days of treatment. HZ is a rare presentation in healthy children and needs a high index of suspicion to diagnose in cases with vesicular eruptions. In our case, the intrauterine infection is the source of latent VZV. HZ may not indicate that the child is immunocompromised.

Keywords: Acyclovir, children, herpes zoster, varicella-zoster virus, vesicular eruptions


How to cite this article:
Mohakud NK, Jishnu K R. A rare case of Herpes Zoster in a child involving dermatomes V1 and V2. Med J DY Patil Vidyapeeth 2022;15:785-7

How to cite this URL:
Mohakud NK, Jishnu K R. A rare case of Herpes Zoster in a child involving dermatomes V1 and V2. Med J DY Patil Vidyapeeth [serial online] 2022 [cited 2022 Nov 26];15:785-7. Available from: https://www.mjdrdypv.org/text.asp?2022/15/5/0/336736




  Introduction Top


Herpes zoster (HZ) (shingles) is due to reactivation of latent varicella-zoster virus (VZV) present in a posterior root ganglion or cranial root ganglia following primary infection. During the viremic stage VZV infection, T-cells get infected and reach the neuronal cell bodies. VZV multiplies inside the neurons without cell death lead to ceasion of proliferation and establishment of latency.[1] The latent virus may get activated due to alteration of the host immunity and travels along the sensory nerve axons and vesicular rash involves in one to two dermatomes.[2] Pediatric cases may be attributed to the exposures from mother during intrauterine period, prior history of chicken pox, or child has taken live attenuated varicella zoster vaccine.[3],[4] HZ incidence is 230/100,000 person-years in 1–18 years' age group.[5] Possibility of HZ among chickenpox-vaccinated children is around 14 cases/100,000 person-year.[6] Furthermore, adverse effect of HZ noted following chickenpox vaccination is approximately 8.6%, mostly in the first 2 weeks after the administration of vaccine.[7] Although HZ is found in immunocompromised children, it is unusual in immunocompetent children. It is diagnosed clinically by unilateral vesicular eruption involving a dermatome or dermatomes.


  Clinical Description Top


A 2 ½-year-old male healthy child presented with right sided painful, vesicular rashes with indurated margin, blisters and crusts on upper cheek, periorbital area, temporal and nasal area of 3 days' duration [Figure 1]. The symptoms start with pain, burning, tingling, or itching on one part of the right side of the face. The child was born out of nonconsanginous marriage. Mother had a history of chicken pox in the second trimester of pregnancy. The child had no history of exposure to VZV or similar rashes in the past. He was immunized as per universal immunization program schedule and not taken VZV vaccine. On examination, lesions were in the dermal distribution of V1 and V2 segment. No lesions found in the other parts of the body. The presence of discharge and matting of eye lashes and the child was unable to open his left eye. Opthalmological evaluation reveals viral conjunctivitis of the left eye. He had a persistent frontal and temporal headache on the day 10 of the disease. Computed tomography scan of the brain was done inview of extensive lesions in such a small kid to exclude viral meningitis, encephalitis or mastoiditis or any space-occupying lesions, which reveals no abnormality.
Figure 1: Crusted lesions and grouped vescicles with indurated base on the right side extending from temporal, periorbital, side of the nose and upper part of the lip corresponding to V1 and V2 dermatomes on day 3

Click here to view


Management and outcome

Examination of complete blood count reaveled leukocytosis (total leukocyte count 13,000/cmm) and lymphocytosis (lymphocytes 68%, neutrophil 27%, eosinophil 4%, and monocyte 1%). C-reactive protein was 32 mg/dl indicating increased acute-phase reactant. The child was clinically diagnosed with a case of HZ. In view of pain, paracetamol was started at a dose of 15 mg/kg 8 hourly and levocetrizine once daily before food for itching. Ofloxacin eye drop was put five times a day for 5 days. Acyclovir at a dose 20 mg/kg/dose orally every 6 hourly given for a period of 1 week. He became asymptomatic by day 5 and lesions get cleared in 12 days [Figure 2]. No complications were noted after 2 weeks of follow-up.
Figure 2: Lesions subsided with hypopigmented marks and one big lesion with remaining crust on day 10

Click here to view



  Discussion Top


Menifestations of HZ in cases of children are rare compared to the adults. HZ may occurs few weeks to years after exposure to VZV. The child had neither taken HZV vaccine nor had any history of exposure to wild VZV. In our case, the infection might have come through intrauterine route as other possibilities of VZV infection is excluded. Few of cases of HZ was detected in healthy children in a study attributing to HZV infection in utero.[4] The T-cell-mediated immunity is the most important component to kill the intracellular organism. A decrease in cell-mediated immunity is associated with reactivation of VZV. It is to be noted that immunosupression of VZV-specific cellular immunity due to chemotherapy or prolong use of steroid or T-cell destruction in the HIV children may results in reactivation of latent VZV.[8] Besides, natural-killer cells, lymphocytes, and cytokines are reportedly less in toddler and absence of anti-IgG for VZV leads reactivation of latent VZV.[2]

The diagnosis is mostly by clinical clinical examination. Characteristic vesiculopostular lesion with indurated base extending over a particular dermatome are found. Sometimes, tzanck smear is done from the vesicles to look for multineucleated giant cells.[5] Methods such as anti-immunoglobulin M VZV, direct fluorescent antibody tests, and viral culture are raely done.[3] Differential diagnosis includes zosteriform herpes simplex, bullous impetigo, and insect bite reactions.

Specific treatment includes acyclovir oral dose of 20 mg/kg body weight every 6 hourly for 5–8 days or for 2 days from the last new lesions. Symptomatic management requiring paracetamol (15 mg/kg/dose) for pain, cetrizine, and emollients to prevent pruritus of skin.[9] Corticosteroids may be used in cases with facial nerve palsy, polyneuritis, evidence of peripheral nerve compression, and involvement of the central nervous system.[9]

This child get rid of the symptoms in a week and does not suffer from any complications. However, sequelae such as encephalitis, Ramsay Hunt syndrome, HZ ophthalmicus, postherpetic neuralgia, and disseminated HZ may occur.[10]


  Conclusion Top


HZ is a rare presentation in healthy children and needs a high index of suspicion to diagnose in cases with vesicular eruptions. HZ may not indicate that the child is immunocompromised.

Lessons learnt

  • HZ manifestation involving multiple dermatomes in a healthy child
  • HZ out of intrauterine transmission in a healthy child.


Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Kennedy PG. Varicella-zoster virus latency in human ganglia. Rev Med Virol 2002;12:327-34.  Back to cited text no. 1
    
2.
Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010;48 Suppl 1:S2-7.  Back to cited text no. 2
    
3.
Mitra B, Chopra A, Talukdar K, Saraswat N, Mitra D, Das J. A clinico-epidemiological study of childhood herpes zoster. Indian Dermatol Online J 2018;9:383-8.  Back to cited text no. 3
[PUBMED]  [Full text]  
4.
Katakam BK, Kiran G, Kumar U. A prospective study of herpes zoster in children. Indian J Dermatol 2016;61:534-9.  Back to cited text no. 4
[PUBMED]  [Full text]  
5.
Peterson N, Goodman S, Peterson M, Peterson W. Herpes zoster in children. Cutis 2016;98:93-5.  Back to cited text no. 5
    
6.
Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 1991;325:1545-50.  Back to cited text no. 6
    
7.
Willis ED, Woodward M, Brown E, Popmihajlov Z, Saddier P, Annunziato PW, et al. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience. Vaccine 2017;35:7231-9.  Back to cited text no. 7
    
8.
Kurlan JG, Connelly BL, Lucky AW. Herpes zoster in the first year of life following postnatal exposure to varicella-zoster virus: Four case reports and a review of infantile herpes zoster. Arch Dermatol 2004;140:1268-72.  Back to cited text no. 8
    
9.
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44 Suppl 1:S1-26.  Back to cited text no. 9
    
10.
Arikawa J, Asahi T, Au WY. Zoster (shingles, herpes zoster). Andrews' Diseases of the Skin. 11th ed. Philadelphia, PA: Saunders/Elsevier. 2011:372-6.  Back to cited text no. 10
    


    Figures

  [Figure 1], [Figure 2]



 

Top
   
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
  Introduction
  Clinical Description
  Discussion
  Conclusion
   References
   Article Figures

 Article Access Statistics
    Viewed663    
    Printed36    
    Emailed0    
    PDF Downloaded41    
    Comments [Add]    

Recommend this journal